(PharmaNewsWire.Com, June 25, 2021 ) According to the new market research report Amniocentesis Needle Market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%.
Factors driving the growth of this market include the high accuracy of amniocentesis, increase in the median age of first-time motherhood, and increasing prevalence of congenital disorders.
100–150 mm segment is estimated to account for the largest market share in 2017
By type, the amniocentesis needles market is classified into needles of length 100 – 150 mm, larger than 150 mm, and smaller than 100 mm. The 100–150 mm segment is expected to lead the global amniocentesis needles market in 2017. Factors driving the growth of this segment include the wide use of these needles on account of their optimal length.
The amniocentesis segment is expected to dominate the market in 2017
By procedure, the market is segmented into amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis. The amniocentesis segment is expected to account for the largest share of the global amniocentesis needles market in 2017. Increasing burden of chromosomal disorders, increasing maternal age & BMI, and high reliability of the amniocentesis technique are the major factors responsible for the dominant share of this segment.
Hospitals are estimated to command the largest share of the market during the forecast period
On the basis of end user, the amniocentesis needles market is categorized into hospitals, diagnostic centers, clinics, and other end users. The hospitals segment is estimated to account for the largest share of the global amniocentesis needles market during the forecast period. The presence of expert personnel and advanced medical equipment in hospitals are the key factors driving the growth of this end-user segment.
Key players in the Amniocentesis Needle Market include Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).
North America is estimated to command the largest share of the market
Based on region, the amniocentesis needles market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the amniocentesis needles market in 2017. This is attributed to factors such as increasing number of programs to promote prenatal diagnosis, rapid economic development, and increasing healthcare expenditure in the region as compared to other regions.
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
